Lexicon Pharmaceuticals
LXRX
LXRX
110 hedge funds and large institutions have $479M invested in Lexicon Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 38 increasing their positions, 29 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
18% less capital invested
Capital invested by funds: $583M → $479M (-$104M)
36% less call options, than puts
Call options by funds: $462K | Put options by funds: $724K
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
110
Holding in Top 10
1
Calls
$462K
Puts
$724K
Top Buyers
| 1 | +$1.09M | |
| 2 | +$1.01M | |
| 3 | +$984K | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$849K |
| 5 |
Millennium Management
New York
|
+$698K |
Top Sellers
| 1 | -$3.13M | |
| 2 | -$1.61M | |
| 3 | -$1.27M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$964K |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$610K |